MedKoo Biosciences

About us  |  Services  |  Products  |  News  |  Careers  |  Contact us

 

 

 

 

Back to products

Browse products

Approved anticancer agents

Anticancer agents in trials

Anticancer molecular libraries

Other drug agents

Bio-reagents and biochemicals

 



 

 

 

 

 

 

 

 

 

 


 

 

 

 

Back to products

Browse products

Approved anticancer agents

Anticancer agents in trials

Anticancer molecular libraries

Other drug agents

Bio-reagents and biochemicals

 



 

 

 

 

 

 

 

 

 

 


 

 

 

 

Back to products

Browse products

Approved anticancer agents

Anticancer agents in trials

Anticancer molecular libraries

Other drug agents

Bio-reagents and biochemicals

 



 

 

 

 

 

 

 

 

 

 


 

 

 

 

Back to products

Browse products

Approved anticancer agents

Anticancer agents in trials

Anticancer molecular libraries

Other drug agents

Bio-reagents and biochemicals

 



 

 

 

 

 

 

 

 

 

 


 

 

 

 

Back to products

Browse products

Approved anticancer agents

Anticancer agents in trials

Anticancer molecular libraries

Other drug agents

Bio-reagents and biochemicals

 



 

 

 

 

 

 

 

 

 

 


 

 

 

 

Back to products

Browse products

Approved anticancer agents

Anticancer agents in trials

Anticancer molecular libraries

Other drug agents

Bio-reagents and biochemicals

 


 

 

MedKoo's special collection

Anticancer molecular libraries

 Note: This webpage will be completed in next few months, which is being constructed mainly based on Dr. Qingqi Chen's new book entitled "Anticancer Small Molecular Libraries" ISBN: 9787030264473, published by Science Press, Beijing, China (Feb 2010).  Please visit this page shortly. Please inquire any agents listed in our webpages.

  

AKT inhibitors

Anti-angiogenesis agents

Vascular disrupting agents (VDAs)

VEGFR (PDGFR) inhibitors

EGFR (HER) inhibitors

Anti-metastasis agents

Anti-metabolite agents

Adenosine deaminase inhibitors

Anti-folate agents

Purine-related anti-metabolite agents

Pyrimidine-related anti-metabolite agents

Ribonucleotide reductase inhibitors

TS inhibitors (thymidylate synthase inhibitors)

Aurora kinase inhibitors

BCL-2 inhibitors (B-Cell lymphoma 2 inhibitors)

BCR-ABL inhibitors

Bioreductive agents

CA inhibitors (carbonic anhydrase inhibitors)

Cancer stem cell inhibitors

Cell cycle checkpoint inhibitors

CDK inhibitors (Cyclin-dependent kinase inhibitors)

c-Kit inhibitors

c-Met inhibitor

Cyclooxygenase inhibitors

DNA targeting agents

DNA-cleaving agents

DNA-cross-linking agents

Aziridine-related cross-linking agents

Bis-methylsulfate cross-linking agents

Cyclopropane-related cross-linking agents

Epoxide-related cross-linking agents

Nitrogen mustard

Nitrosourea mustard

Phosphoramide mustard

DNA intercalating agents

Anthraquinone-related DNA  intercalating agents

Tetracyclic-related DNA  intercalating agents

DNA-PK inhibitors

DNA-sequence targeting agents

DNA G-quadruplex stabilizers

DNA Monoalkylation agents

Platinum anticancer agents

Topoisomerase inhibitors

Acridine-related topoisomerase inhibitors

Camptothecin-related topoisomerase inhibitors

Ellipticine-related topoisomerase inhibitors

Naphthalimide-related topoisomerase inhibitors

Naphthoquinone-related topoisomerase inhibitors

Podophyllotoxin-related topoisomerase inhibitors

Rebeccamycin-related topoisomerase inhibitors

Thia-anthrone-related topoisomerase inhibitors

Epigenetic-based therapeutic agents

Farnesyl transferase inhibitors

FLT3 inhibitors  (FMS-like tyrosine kinase 3 inhibitors)

HDAC inhibitors (Histone deacetylase inhibitors)

Hormone-related anticancer agents

SERMs (selective estrogen-receptor modulators)

Triphenylethylene-related SERMs

Steriod-related SERMs

Other-structure-related SERMs

SPRMs (selective progesterone receptor modulators)

STS inhibitors (Steroid sulfatase inhibitors)

Aromatase inhibitors

Non-steroid aromatase inhibitors

Steroid aromatase inhibitors

LH-RH related agents (luterinizing hormone-releasing hormone related agents)

LH-RH agonists (luterinizing hormone-releasing hormone agonists)

LH-RH receptor antagonists (luterinizing hormone-releasing hormone antagonists)

Peptide-related LH-RH receptor antagonists

Non-peptide-related LH-RH receptor antagonists

Anti-androgen agents

Steroid anti-androgen agents

Non-steroid anti-androgen agents

Somatostain-related anticancer agents

HSP inhibitors (heat shock protein inhibitors)

Hypoxia cytotoxic agents

IGF-IR inhibitors  (insulin-like growth factor I receptor inhibitors)

IMPDH inhibitors (inosine 5'-monophosphate dehydrogenase inhibitors)

JAK inhibitors ( Janus Kinase Inhibitors)

JNK inhibitors (c-Jun N-trminal kinase inhibitors)

KSP inhibitors (Kinesin spindle protein inhibitors)

LTB4 receptor antagonists (Leukotriene B4 antagonists)

MEK inhibitors

MGMT/AGT inhibitors

Microtube inhibitors

Vinca alkaloids-related microtube inhibitors

Taxanes-related microtube inhibitors

Macrocyclic-related microtube inhibitors

Small peptides-related microtube inhibitors

Bicyclic-related microtube inhibitors

Benzenesulfonamide-related microtube inhibitors

Combrestatin-related microtube inhibitors

Benzophenone-related microtube inhibitors

Long-chain marine products-related microtube inhibitors

MMP inhibitors  (Matrix metalloproteinase inhibitors)

mTOR inhibitors (mammalian target of rapamycin inhibitors)

MGMT/AGT inhibitors

Multiple kinase inhibitors

PARP inhibitors (poly(adenosine diphosphate ribose) polymerase inhibitors)

P-glycoprotein inhibitors (MDR resistance inhibitors)

Photodynamic therapy drugs (PDT drugs/photosensitizers)

Porphyrin-related PDT agents

Non-porphyrin-related PDT agents

PI3K inhibitors (phosphoinisitide-3 kinase inhibitors)

PLK-1 inhibitors (Polo-like kinase inhibitors)

Proteasome inhibitors

Radiosensitizing agents

SPR modulators (Selective progesterone receptor)

STAT3 inhibitors (signal transduction and activator of transcription inhibitors)

Supportive care agents

Protective agents for chemotherapy and radiotherapy

Antiemetic agents

5-HT3 receptor antagonists

NK1 receptor antagonists  

Cancer pain management agents

Survivin inhibitors

Targeted therapeutic agents

ADEPT agents (antibody director enzyme prodrug therapy agents)

GDEPT agents (Gene-directed enzyme prodrug  therapy agents)

PDEPT agents (polymer-directed enzyme prodrug therapy agents)

Telomerase inhibitors

Thioredoxin reductase inhibitors

 

 

Contact MedKoo:

Email: sales@medkoo.com

 

About us  |  Services  |  Products  |  News  |  Careers  |  Contact us

© MedKoo Biosciences. All Rights Reserved

 

 

 

hit counter